Company profile: Cogent Biosciences
1.1 - Company Overview
Company description
- Provider of therapies for solid cancer tumors as a biotechnology company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cogent Biosciences
Nivalis
HQ: United States
Website
- Description: Provider of clinical-stage pharmaceutical therapies designed to preserve intracellular S-nitrosoglutathione (GSNO), an endogenous molecule with cell signaling effects implicated in cystic fibrosis pathophysiology; developing a novel class of disease-modifying treatments, including lead candidate N91115 initially targeting CF patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nivalis company profile →
Healx
HQ: United Kingdom
Website
- Description: Provider of AI-driven rare disease drug discovery and development, leveraging generative AI and machine learning to identify and repurpose drug candidates. Offerings include Healnet, preclinical testing, clinical trials, regulatory approval and access, and making approved treatments available to patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healx company profile →
Perlara
HQ: United States
Website
- Description: Provider of precision drug discovery services: drug repurposing screening to identify potential treatments and advise on experimentation and clinical translation; CureMap disease analyses with literature review, ongoing research, expert interviews, and partner identification; scientific advisory for reviews, client meetings with scientific partners, and translation guidance; and Guided Cures planning with researchers and clinicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Perlara company profile →
Comet Therapeutics
HQ: United States
Website
- Description: Provider of therapies designed to treat orphan neurological disorders; develops treatments to restore dysregulated CoEnzyme A metabolism through a CoEnzyme metabolism platform, enabling physicians to address profound unmet medical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comet Therapeutics company profile →
Soleno Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies, developing DCCR (Diazoxide Choline) Extended-Release tablets, a once-daily oral treatment in development for Prader-Willi syndrome (PWS) and other rare endocrine disorders, designed to reduce hyperphagia, improve behavior, and manage metabolic health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Soleno Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cogent Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cogent Biosciences
2.2 - Growth funds investing in similar companies to Cogent Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cogent Biosciences
4.2 - Public trading comparable groups for Cogent Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →